MHMartine Hendriksma

Martine Hendriksma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martine Hendriksma has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Elisabeth V. Sjögren

    Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    7 shared publications
  • Bas Joris Heijnen

    Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands

    3 shared publications
  • Peter Paul G. van Benthem

    Department of Otorhinolaryngology/Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    3 shared publications
  • Stephanie D. Mes

    Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    3 shared publications
  • Antonius P. M. Langeveld

    Department of ENT, Head and Neck Surgery H5-Q, Leiden University Medical Center, Leiden, The Netherlands

    2 shared publications
  • Bas J. Heijnen

    Department of Otorhinolaryngology/Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Laryngeal reinnervation for unilateral vocal fold paralysis in adults; a systematic review of the literature for the clinician

    by Stephanie D. Mes, Bas J. Heijnen, Martine H. Hendriksma, Antonius P.M Langeveld, Emilie A.C. Dronkers, Elisabeth V. Sjögren

    Purpose: Unilateral vocal fold paralysis (UVFP), resulting from recurrent laryngeal nerve injury, significantly impairs phonation and reduces quality of life. Laryngeal reinnervation, including ansa-to-recurrent (ansaNSR) and nerve-muscle pedicle reinnervation combined with arytenoid adduction (NMPR + AA), has gained attention as a durable treatment option. This systematic review aims to evaluate the outcomes of laryngeal reinnervation, identify predictive factors and highlight knowledge gaps relevant to clinical practice. Methods: A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and Emcare identified 42 studies. Outcome measures included perceptual, acoustic, aerodynamic, videostroboscopic and patient-reported outcomes. The risk of bias was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Weighted mean improvements were calculated for clinically relevant parameters. Results: We included forty-two studies ( N = 1 859 patients) in our review. These studies demonstrated high rates of voice improvement, primarily based on data from the ansaNSR ( N = 1 369) and NMPR + AA ( N = 278) techniques. Age and duration of denervation emerged as the most influential predictive factor. Younger patients (< 60 years) and those with shorter denervation periods (< 2 years) had better outcomes, although successful results were also observed beyond these thresholds. The predictive value of preoperative laryngeal electromyography (LEMG), etiology of UVFP and clinical presentation remains inconclusive. Conclusion: Laryngeal reinnervation (ansaNSR and NMPR + AA) is effective for UVFP, offering durable voice improvements with minimal complication rates. Future research should focus on standardizing outcome measurements, clarifying predictive factors and refining patient selection to enhance clinical decision-making.


  • Open Access

    European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification

    by Malgorzata Wierzbicka, Agatha Baidun, Andy Bertolin, Marco Lionello, Giovanni Succo, Berit Verbist, Davide Farina, Martine Hendriksma, Marc Remacle, Ricard Simo, et al.

    Early glottic cancer has an excellent prognosis provided that recurrences are detected in a timely manner. However, current guidelines lack specific recommendations for intervals or interventions during follow-up, and primarily advocate surveillance in the most advanced stages where the benefits are actually the lowest. This consensus statement introduces a risk-stratification-guided follow-up schedule for T1-T2N0 patients, aiming to optimize oncologic and functional outcomes while ensuring early detection of residual or recurrent disease to preserve organ function. Separate protocols are outlined for surgical and non-surgical patients, including endoscopic examination, radiological imaging, and thyroid function screening. Also, the pathway to reach this routine observation phase is described, specifying the criteria and timing of a second-look microlaryngoscopy.


  • Open Access

    Long-term outcomes of bilateral medialisation thyroplasty in patients with vocal fold atrophy with or without sulcus

    by Emke M.J.M. van Den Broek, Bas J. Heijnen, Jens C. van der Valk, Martine Hendriksma, Antonius P.M. Langeveld, Peter Paul G. van Benthem, Elisabeth V. Sjögren

    Evaluate long-term voice outcome after bilateral medialisation thyroplasty in glottic insufficiency due to vocal fold atrophy with or without sulcus. Patients after medialisation thyroplasty for vocal fold atrophy with or without sulcus were identified. Long-term post-operative subjective voice outcomes (> 1 year) using Voice Handicap Index-30, subjective ratings on voice aspects and study-specific questionnaire were compared to pre-operative and shorter-term (1 year) values. Thirty-six patients were identified, of which 26 were included (16 atrophy, 10 sulcus) with median follow up of 6.7 years. Mean Voice Handicap Index score at > 1 year (40.0) showed clinically relevant (≥ 15 for groups) and statistically significant improvement compared to pre-operative score (58.1) and remained stable compared to post-operative score (35.7) at one year. Ten patients (56 per cent) reported clinically relevant improvement (≥ 10) after more than five years. Long-term improvement in subjective voice outcomes is attainable in a significant proportion of patients undergoing bilateral medialisation thyroplasty for atrophy with or without sulcus.


  • Open Access

    Long-term functional outcomes in tumour stage T2 glottic carcinoma after radiotherapy

    by M. Hendriksma, B.J. Heijnen, B.M. Verbist, M A de Jong, A.P.M. Langeveld, P.P.G. van Benthem, E.V. Sjögren

    Objective: To evaluate the long-term functional outcomes in patients who received primary radiotherapy for tumour–node stage T2N0 glottic carcinoma, stratified for tumour extension.Methods: A cross-sectional study was performed on patients who were treated with radiotherapy for T2N0 glottic carcinoma. Four questionnaires were used to measure different aspects of functional outcome. In addition, objective evaluation and perceptual analysis were performed.Results: Fourteen patients were included in this study. The median time between the start of radiotherapy and assessment was 42 months (range, 26–143 months). Patients reported high-level functioning, with low symptom scores and good swallowing function, and showed a median dysphonia grade of 1.5. The median Voice Handicap Index-30 score was 17.5.Conclusion: Patients with T2N0 glottic carcinoma treated with radiotherapy had good long-term quality of life, with low symptom scores, good swallowing functioning and slightly elevated voice outcome parameters.


  • Voice Outcome After Carbon Dioxide Transoral Laser Microsurgery for Glottic Cancer According to the European Laryngological Society Classification of Cordectomy Types – A Systematic Review

    by Elisabeth Sjogren, Martine Hendriksma, Cesare Piazza, Dana M. Hartl, Carlos Suarez, Oded Cohen, Remco de Bree, Miquel Quer, Vincent Vander Poorten, Juan Pablo Rodrigo, et al.


  • Multidimensional assessment of voice quality after injection augmentation of the vocal fold with autologous adipose tissue or calcium hydroxylapatite

    by Stephanie D. Mes, Edela Smajlović, Bas J. Heijnen, Martine Hendriksma, Jeroen C. Jansen, Antonius P. M. Langeveld, Elisabeth V. Sjögren

    Purpose The purpose of this study was to evaluate short- and long-term outcome of injection augmentation with autologous adipose tissue (AAT) and calcium hydroxylapatite injection (CAHA) in patients with a unilateral vocal fold paralysis (UVFP). Design/methods A retrospective cohort study was performed in patients diagnosed with UVFP, who had received injection augmentation with AAT or CAHA. Multidimensional voice analysis was performed before, 3 and 12 months after injection. This analysis included patient self-assessment (Voice Handicap Index-30), perceptual (overall dysphonia grade according to the GRBAS scale), aerodynamic (MPT, s/z ratio) and acoustic (fundamental frequency, dynamic range) parameters. Effects were assessed using a linear mixed model analysis. Results Forty-six patients were available for evaluation, with a total of 53 injection augmentations (AAT n = 39; CAHA n = 14). We found significant improvement of patient self-assessment and perceptive voice outcome at 3 months, which were maintained at 12 months. In the CAHA group, s/z ratio and dynamic range of extreme frequencies also improved significantly over time. No statistically significant differences were found between the two treatments (AAT vs. CAHA). No major complications were reported. Conclusion This study, using a guide-line recommended panel of outcome parameters, shows a high success rate of injection augmentation with AAT or CAHA for patients with UVFP at 12 months with significant improvement in most voice outcome parameters, although voices do not completely normalize. There is no significant difference in outcome between the two materials.


  • Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis

    by Stephanie D. Mes, Martine Hendriksma, Bas J. Heijnen, Ben F. J. Goudsmit, Jeroen C. Jansen, Antonius P. M. Langeveld, Elisabeth V. Sjögren

    Objective To evaluate the short- and long-term voice outcomes after unilateral medialization thyroplasty (MT) and unilateral medialization thyroplasty with arytenoid adduction (MT + AA) in patients with unilateral vocal fold paralysis. Methods Voice outcomes were assessed preoperatively, and postoperatively at 3 and 12 months according to a standardized protocol. Voice assessment was performed using Voice Handicap Index (VHI), GRBAS Grade, Maximum Phonation Time (MPT), s/z-ratio and subjective numeric rating scales on voice quality, effort, performance and influence on life. Results Sixty-one patients were included (34 MT and 27 MT + AA). Significant pre- to postoperative improvements were seen in all voice outcome parameters. No significant differences in post-operative values were identified between the groups. Conclusion Based on our findings, we conclude that patients with unilateral vocal fold paralysis who undergo MT and MT + AA achieve comparable and significant long time voice improvement, although voices do not completely normalize. We also conclude that this does not mean that AA is a superfluous procedure, but can indicate the accurate identification of patients in need of the additional AA procedure based on clinical parameters.


  • Open Access

    Patient-reported factors that influence the vestibular schwannoma treatment decision: a qualitative study

    by O. M. Neve, G. Soulier, M. Hendriksma, A. G. L. van der Mey, A. van Linge, P. P. G. van Benthem, E. F. Hensen, A. M. Stiggelbout

    Purpose: In cases of small- to medium-sized vestibular schwannomas, three management strategies can be opted for: active surveillance, surgery or radiotherapy. In these cases, the patient’s preference is pivotal in decision-making. The aim of this study was to identify factors that influence a patient’s decision for a particular management strategy. Methods: A qualitative inductive thematic analysis was performed based on semi-structured interviews. Eighteen patients with small- to medium-sized vestibular schwannomas were interviewed. All patients were diagnosed or treated at one of the two participating university medical centers in the Netherlands. Results: Ten themes were identified that influenced the decision, classified as either medical or patient-related. The medical themes that emerged were: tumor characteristics, the physician’s recommendation, treatment outcomes and the perceived center’s experience. The patient-related themes were: personal characteristics, anxiety, experiences, cognitions, logistics and trust in the physician. Conclusion: Knowledge of the factors that influence decision-making helps physicians to tailor their consultations to arrive at a true shared decision on vestibular schwannoma management.


  • Open Access

    Quality of life (QoL) evaluation of children using cochlear implants: agreement between pediatric and parent proxy-QoL reports

    by Martine Hendriksma, Hanneke Bruijnzeel, Aren Bezdjian, Emily Kay-Rivest, Sam J. Daniel, Vedat Topsakal

    Objectives: Cochlear implants are known to significantly improve the quality of life (QoL) of implanted children. However, variability exists between self-reported outcomes and parental-reported QoL questionnaires. We evaluated the QoL agreement between children and their parents following cochlear implantation and determined which factors lead to increased agreement. Methods: A cross-sectional study was performed including pediatric cochlear implant recipients and their parents. We evaluated postoperative QoL using The Pediatric Quality of Life Inventory (PedsQL). To assess agreement between pediatric and parental QoL perception, PedsQL intra-class correlations (ICCs) were calculated. Results: Thirty-five children and their parents completed QoL questionnaires. Children who were evaluated between 8–12 years of age reported highest absolute total and subscale PedsQL scores. Highest agreement was found amongst parents and children when: (1) children were between 8–12 years at QoL assessment (ICC: between 0.917[95%CI: 0.676–0.981] and 0.972[95%CI: 0.882–0.994]), and (2) when evaluating the physical health QoL domain (ICC: 0.964[95%CI: 0.849–0.992]). Conclusions: This study demonstrates high agreement (ICC > 0.8) between pediatric and parental QoL report in children aged between 8–12 years at QoL assessment. Therefore, results confirm that: (1) QoL agreement between pediatric self-report and parent proxy-report is high in chronically ill children and (2) children using cochlear implants can reliably report QoL between 8–12 years.


  • Open Access

    Survival and Prognostic Factors for Outcome after Radiotherapy for T2 Glottic Carcinoma

    by Martine Hendriksma, Marc A.P. van Ruler, Berit M. Verbist, Martin A. de Jong, Ton P.M Langeveld, Peter Paul G. van Benthem, Elisabeth V. Sjögren

    Background: Local recurrence after radiotherapy for T2 glottic carcinoma remains an issue and identifying patients at risk for relapse is, therefore, important. This study aimed to assess the oncological outcomes and prognostic factors in a consecutive series of patients treated with radiotherapy for T2N0 glottic carcinoma. Methods: Patients with T2N0 glottic carcinoma treated with radiotherapy were included in this retrospective study. Five- and ten-year local control (LC), overall survival (OS), disease-specific survival (DSS), and laryngeal preservation (LP) rates were calculated with the Kaplan–Meier method. The impact of prognostic variables was evaluated with the log-rank test. Results: Ninety-four patients were included for analysis. LC, OS, DSS, and LP rates were 70.5, 63.7, 86.0, and 74.7%, respectively at five years and 65.8, 41.0, 75.6, and 72.4% at 10 years. In total, 46 scans were included in the analyses. Vertical involvement of the anterior commissure on imaging showed a significant impact on LC. Conclusions: In accordance with previously described surgical risk factors, we identified vertical involvement of the anterior commissure on imaging as a prognostic factor for radiation failure.